Gollob Jared
Chief Medical Officer · 24 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 2,519 | $85.04 | $214,206.69 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,437 | $85.78 | $123,266.87 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 492 | $84.00 | $41,326.28 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 447 | $86.62 | $38,721.24 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,048 | $89.66 | $273,275.76 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,510 | $87.75 | $132,503.86 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,055 | $88.50 | $93,367.92 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Award | 17,650 | $0.00 | $0.00 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 18,357 | $88.02 | $1.6M | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 13,759 | $87.37 | $1.2M | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 8,562 | $90.12 | $771,629.70 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,929 | $89.43 | $351,356.33 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,300 | $91.46 | $301,830.87 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 49,307 | $5.33 | $262,806.31 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,400 | $92.19 | $129,066.00 | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Sale | 29,264 | $60.37 | $1.8M | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Sale | 14,896 | $62.72 | $934,326.28 | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Sale | 8,963 | $61.49 | $551,160.86 | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Sale | 6,453 | $63.09 | $407,099.12 | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 22,210 | $2.08 | $46,196.80 | filing |
| 2025-10-15 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 28,999 | $1.31 | $37,988.69 | filing |
| 2025-10-13 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,114 | $60.00 | $186,840.00 | filing |
| 2025-10-13 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 673 | $2.08 | $1,399.84 | filing |
| 2025-10-13 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 800 | $1.31 | $1,048.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.